Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We have maintained our long-term Neutral recommendation on Newfield Exploration Company ( NFX - Analyst Report ) – a Houston, Texas-based independent energy company engaged in the exploration and production (E&P) of crude oil and natural gas.
The company started the year on a positive note and reported strong oil production of 5.9 million barrels, representing 47% of its total first quarter 2012 production. Total quarterly production of 76.1 billion cubic feet equivalent (Bcfe), comprising 53% natural gas, increased 6.4% from the year-earlier period. This improvement was mainly on the back of successful drilling results in the Uinta and Williston Basins. For the second half of the year, oil output is expected to be over 50% of its total production.
Newfield’s diversified portfolio of assets provides both flexibility and significant growth potential. We expect the company’s reserve potential in the Southern Alberta Bakken, Wasatch oil, Uinta Basin and a new resource play to be liquid-rich catalysts for the stock. Notably, in response to strong quarterly production, Newfield raised its 2012 production guidance by approximately 1% with a focus on oil and liquids-rich gas plays within the Uinta and Williston basins, the Anadarko Basin and offshore Malaysia. Whereas, capital expenditure for the year remains unchanged in the $1.5–$1.7 billion range.
However, we believe that the company’s increased expectation for production appears to be due entirely to the first quarter production beat and suggests a lower range for the balance of the year.
Though we remain positive on Newfield Exploration’s emerging resource play development programs, the low natural gas price environment could weigh on the stock since 60% of Newfield’s reserves accounts for natural gas.
Again, Newfield’s Rockies and Gulf Coast-centered asset portfolio, along with its lack of meaningful exposure to the emerging shale plays, is a competitive disadvantage. We believe the company is dependent on the successful development of its liquid-rich plays in the Uinta Basin, Granite Wash and North Dakota Bakken to reach its production targets and thereby investor expectations. Hence, any region-specific recurrence of issues could have adverse effects on the company.
Hence, considering the above discussions we see limited upside potential for the Newfield shares. Newfield, which competes with Pioneer Natural Resources Co ( PXD - Analyst Report ) and Denbury Resources Inc ( DNR - Analyst Report ) , retains a Zacks #3 Rank, which is equivalent to a short-term Hold rating for a period of one to three months.
Read the full reports :
Analyst Report on NFX
Analyst Report on PXD
Analyst Report on DNR